Literature DB >> 23126244

Medical versus surgical termination of pregnancy in primigravid women--is the next delivery differently at risk? A population-based register study.

J Männistö1, M Mentula, A Bloigu, E Hemminki, M Gissler, O Heikinheimo, M Niinimäki.   

Abstract

OBJECTIVE: To compare the effect of medical versus surgical termination of pregnancy (TOP), performed in primigravid women, on subsequent delivery.
DESIGN: Population-based register study.
SETTING: Finland 2000-2009. POPULATION: All primigravid women (n = 8294) who underwent TOP during first trimester of pregnancy by medical (n = 3441) or surgical (n = 4853) method, and whose subsequent pregnancy resulted in singleton delivery.
METHODS: The women were identified in the Finnish Register of Induced Abortions, and the data were linked to the Medical Birth and the Hospital Discharge Registries. MAIN OUTCOME MEASURES: Risk of preterm birth, low birthweight, small-for-gestational-age (SGA) infant and placental complications (placenta praevia, placental abruption, retained placenta, placenta accreta).
RESULTS: No statistically significant differences in the incidences of preterm birth (4.0% in the medical group versus 4.9% in the surgical group), low birthweight (3.4% versus 4.0%), SGA infants (2.6% versus 2.9%) or placental complications (2.6% versus 2.8%) emerged between the two groups. After adjusting for various background factors, medical TOP was not associated with significantly altered risks of preterm birth (odds ratio [OR] 0.87, 95% confidence interval [95% CI] 0.68-1.13), low birthweight (OR 0.90, 95% CI 0.68-1.19), SGA infant (OR 0.87, 95% CI 0.64-1.20) or placental complications (OR 0.98, 95% CI 0.72-1.34) versus surgical TOP. In a sub-analysis excluding women who underwent surgical evacuation following the index TOP, medical TOP was associated with a reduced risk of preterm birth (P < 0.01), but the difference became insignificant after adjusting for gestational age at the time of TOP, inter-pregnancy interval, maternal age, cohabitation status, socio-economic status, residence and smoking during pregnancy.
CONCLUSIONS: A history of one medical versus surgical TOP, performed in primigravid women, is associated with similar obstetric risks in the subsequent delivery.
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126244     DOI: 10.1111/1471-0528.12034

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

1.  Induced Abortions and the Risk of Preeclampsia Among Nulliparous Women.

Authors:  Samantha E Parker; Mika Gissler; Cande V Ananth; Martha M Werler
Journal:  Am J Epidemiol       Date:  2015-09-15       Impact factor: 4.897

Review 2.  What contributes to disparities in the preterm birth rate in European countries?

Authors:  Marie Delnord; Béatrice Blondel; Jennifer Zeitlin
Journal:  Curr Opin Obstet Gynecol       Date:  2015-04       Impact factor: 1.927

Review 3.  Recent advances in improving the effectiveness and reducing the complications of abortion.

Authors:  Sharon Cameron
Journal:  F1000Res       Date:  2018-12-02

4.  Subsequent placenta accreta after previous mifepristone-induced abortion: A case report.

Authors:  Peng Zhao; Ying Zhao; Jing He; Xiao-Xia Bai; Jian Chen
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

5.  Changes in association between previous therapeutic abortion and preterm birth in Scotland, 1980 to 2008: a historical cohort study.

Authors:  Clare Oliver-Williams; Michael Fleming; Kirsten Monteath; Angela M Wood; Gordon C S Smith
Journal:  PLoS Med       Date:  2013-07-09       Impact factor: 11.069

6.  Perinatal outcomes after induced termination of pregnancy by methods: A nationwide register-based study of first births in Finland 1996-2013.

Authors:  Situ Kc; Elina Hemminki; Mika Gissler; Suvi M Virtanen; Reija Klemetti
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.